A9568
HCPCSTechnetium tc99m arcitumomab
Official HCPCS Level II long descriptor
Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries
HCPCS Level II code A9568 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Technetium tc99m arcitumomab
Added to HCPCS: 2007-01-01
Nearby codes in A9
- A9559Co57 cyano
- A9560Tc99m labeled rbc
- A9561Tc99m oxidronate
- A9562Tc99m mertiatide
- A9563P32 na phosphate
- A9564P32 chromic phosphate
- A9566Tc99m fanolesomab
- A9567Technetium tc-99m aerosol
- A9569Technetium tc-99m auto wbc
- A9570Indium in-111 auto wbc
- A9571Indium in-111 auto platelet
- A9572Indium in-111 pentetreotide
- A9573Inj, gadopiclenol, 1 ml
- A9574Inj. ferumoxytol, 1 mg
- A9575Inj gadoterate meglumi 0.1ml
- A9576Inj prohance multipack
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.